In the first of a new series, we take a deep dive into the Therapeutic Goods Administration’s SAS-B medicinal cannabis access data dashboard to find out what’s really going on in the industry. This service is available exclusively to Cannabiz premium members. To upgrade your membership and access this article, click here.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

Join or login

Medicinal cannabis patients are getting younger, ‘maler’ and more anxious, though their preference for flower has not been enough to knock oil of its perch, according to TGA data for the first four months of 2022.

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...

Steve has reported for a number of consumer and B2B titles over a journalism career spanning more than three decades. He is a regulator contributor to health journal, The Medical Republic, writing on...